Perceptive Advisors LLC Amicus Therapeutics, Inc. Transaction History
Perceptive Advisors LLC
- $4.77 Billion
- Q1 2024
A detailed history of Perceptive Advisors LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 28,057,456 shares of FOLD stock, worth $278 Million. This represents 6.94% of its overall portfolio holdings.
Number of Shares
28,057,456
Previous 28,057,456
-0.0%
Holding current value
$278 Million
Previous $398 Million
16.98%
% of portfolio
6.94%
Previous 9.71%
Shares
21 transactions
Others Institutions Holding FOLD
# of Institutions
273Shares Held
325MCall Options Held
841KPut Options Held
353K-
Vanguard Group Inc Valley Forge, PA28.2MShares$280 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$272 Million3.89% of portfolio
-
Black Rock Inc. New York, NY22.8MShares$227 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA18.8MShares$187 Million0.04% of portfolio
-
Jpmorgan Chase & CO New York, NY15.7MShares$156 Million0.02% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.78B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...